Literature DB >> 26363872

Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.

Manizheh Mostofi1, Ghodsi Mohammadi Ziarani1, Mohammad Mahdavi2, Alireza Moradi3, Hamid Nadri3, Saeed Emami4, Heshmatollah Alinezhad5, Alireza Foroumadi2, Abbas Shafiee6.   

Abstract

A series of benzofuran-based chalconoids 6a-v were designed and synthesized as new potential AChE inhibitors. The in vitro assay of synthesized compounds 6a-v showed that most compounds had significant anti-AChE activity at micromolar or sub-micromolar levels. Among the tested compounds, 3-pyridinium derivative 6m bearing N-(2-bromobenzyl) moiety and 7-methoxy substituent on the benzofuran ring exhibited superior activity. This compound with IC₅₀ value of 0.027 μM was as potent as standard drug donepezil.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase; Alzheimer's disease; Benzofuran; Docking study; Pyridinium

Mesh:

Substances:

Year:  2015        PMID: 26363872     DOI: 10.1016/j.ejmech.2015.08.061

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors.

Authors:  Roshanak Ghobadian; Roghaieh Esfandyari; Hamid Nadri; Alireza Moradi; Mohammad Mahdavi; Tahmineh Akbarzadeh; Hossein Khaleghzadeh-Ahangar; Najmeh Edraki; Mohammad Sharifzadeh; Mohsen Amini
Journal:  Mol Divers       Date:  2019-03-29       Impact factor: 2.943

2.  Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.

Authors:  Shahrzad Ghafary; Roshanak Ghobadian; Mohammad Mahdavi; Hamid Nadri; Alireza Moradi; Tahmineh Akbarzadeh; Zahra Najafi; Mohammad Sharifzadeh; Najmeh Edraki; Farshad Homayouni Moghadam; Mohsen Amini
Journal:  Daru       Date:  2020-05-05       Impact factor: 3.117

3.  Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.

Authors:  Jin-Shuai Lan; Jian-Wei Hou; Yun Liu; Yue Ding; Yong Zhang; Ling Li; Tong Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

4.  Design, synthesis, and bio-evaluation of new isoindoline-1,3-dione derivatives as possible inhibitors of acetylcholinesterase.

Authors:  Motahareh Hassanzadeh; Farshid Hassanzadeh; Ghadam Ali Khodarahmi; Mahbobe Rostami; Fateme Azimi; Hamid Nadri; Farshad Homayouni Moghadam
Journal:  Res Pharm Sci       Date:  2021-08-19

5.  Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer's disease.

Authors:  Hormoz Pourtaher; Alireza Hasaninejad; Aida Iraji
Journal:  Sci Rep       Date:  2022-09-08       Impact factor: 4.996

Review 6.  Recent developments in the design and synthesis of benzylpyridinium salts: Mimicking donepezil hydrochloride in the treatment of Alzheimer's disease.

Authors:  Saghi Sepehri; Mina Saeedi; Bagher Larijani; Mohammad Mahdavi
Journal:  Front Chem       Date:  2022-09-26       Impact factor: 5.545

7.  Design, synthesis and biological evaluation of edaravone derivatives bearing the N-benzyl pyridinium moiety as multifunctional anti-Alzheimer's agents.

Authors:  Luke S Zondagh; Sarel F Malan; Jacques Joubert
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 8.  Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors.

Authors:  Ginson George; Vishal Payyalot Koyiparambath; Sunitha Sukumaran; Aathira Sujathan Nair; Leena K Pappachan; Abdullah G Al-Sehemi; Hoon Kim; Bijo Mathew
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.